A multidisciplinary team sought to improve COVID-19 testing access for children, while making providers and patients more comfortable with the process.

CHOP psychologists offer strategies to help children recognize their fears, separate the rational from the irrational, and how to deal with or overcome each.

New findings set stage for future targeted therapies for patients with 22q11.2 deletion syndrome, who are 25 times more likely to develop schizophrenia.

The Wood Family, founding family of Wawa, funds momentous gift of $25 million to support new era of fetal medicine at CHOP, advance promising research, and recruit world-class talent.

Safeguard your backyard with proactive information from CHOP’s Poison Control Center.

CHOP Clinical Nurse Sophia Collins and Philly Teen Vaxx Ambassador Angely join Good Day Philadelphia to discuss Philly Teen Week.

A dozen patients have clinical features linked to the genetic variants, and preclinical models reveal more about how they affect normal function.

CHOP clinicians offer a holistic approach to celiac disease management at recent town hall event.

CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.

CHOP researchers have found that MN1 overexpression leads to stabilization of the BAF complex, which leads to overproduction of progenitor and stem cells.